HP
WVE icon

Hound Partners’s Wave Life Sciences WVE Stock Holding History

Hound Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-180,899
Closed -$886K – 126
2021
Q3 		$886K Buy
+180,899
New +$1.1M 0.05% 160
2020
Q4 		– Sell
-430,301
Closed -$3.65M – 141
2020
Q3 		$3.65M Buy
+430,301
New +$4.72M 0.25% 41

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hound Partners's WVE Position: Q4 2021 in Review

Hound Partners sold out of Wave Life Sciences (WVE) in Q4 2021, closing a stake of 180,899 shares — an estimated $886K sold.

Hound Partners first reported a position in WVE in Q3 2020 and held it in 2 quarters. The position peaked at $3.65M in Q3 2020. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2021.

  • Hound Partners reported no remaining Wave Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Hound Partners sold 180,899 Wave Life Sciences shares in Q4 2021, an estimated $886K.
  • Hound Partners first reported a position in Wave Life Sciences in Q3 2020 and held it in 2 quarters.
  • Hound Partners's Wave Life Sciences position peaked at $3.65M in Q3 2020.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2021.

Based on Hound Partners's 13F filing for Q4 2021, filed 14 Feb 2022.